{"id":278309,"date":"2024-10-19T18:45:21","date_gmt":"2024-10-19T18:45:21","guid":{"rendered":"https:\/\/pdfstandards.shop\/product\/uncategorized\/bs-en-iso-5840-22015-tc\/"},"modified":"2024-10-25T15:17:48","modified_gmt":"2024-10-25T15:17:48","slug":"bs-en-iso-5840-22015-tc","status":"publish","type":"product","link":"https:\/\/pdfstandards.shop\/product\/publishers\/bsi\/bs-en-iso-5840-22015-tc\/","title":{"rendered":"BS EN ISO 5840-2:2015 – TC"},"content":{"rendered":"
PDF Pages<\/th>\n | PDF Title<\/th>\n<\/tr>\n | ||||||
---|---|---|---|---|---|---|---|
124<\/td>\n | European foreword <\/td>\n<\/tr>\n | ||||||
125<\/td>\n | Annex ZA (informative) Relationship between this European Standard and the Essential Requirements of EU Directive 93\/42\/EEC on medical devices Table ZA.1 \u2014 Correspondence between this European Standard and Directive 93\/42\/EEC on medical devices <\/td>\n<\/tr>\n | ||||||
128<\/td>\n | Foreword <\/td>\n<\/tr>\n | ||||||
129<\/td>\n | Introduction <\/td>\n<\/tr>\n | ||||||
130<\/td>\n | 1\tScope 2\tNormative references <\/td>\n<\/tr>\n | ||||||
131<\/td>\n | 3\tTerms and definitions <\/td>\n<\/tr>\n | ||||||
133<\/td>\n | 4\tAbbreviations 5\tFundamental requirements <\/td>\n<\/tr>\n | ||||||
134<\/td>\n | 6\tDevice description 6.1\tIntended use 6.2\tDesign inputs 6.2.1\tOperational specifications 6.2.2\tPerformance specifications <\/td>\n<\/tr>\n | ||||||
135<\/td>\n | 6.2.3\tPackaging, labelling, and sterilization 6.3\tDesign outputs 6.3.1\tGeneral 6.4\tDesign transfer (manufacturing qualification) 6.5\tRisk management 7\tDesign verification testing and analysis\/design validation 7.1\tGeneral requirements <\/td>\n<\/tr>\n | ||||||
136<\/td>\n | 7.2\tIn vitro assessment 7.2.1\tTest conditions, sample selection, and reporting requirements <\/td>\n<\/tr>\n | ||||||
137<\/td>\n | 7.2.2\tMaterial property assessment 7.2.3\tHydrodynamic performance assessment <\/td>\n<\/tr>\n | ||||||
139<\/td>\n | 7.2.4\tStructural performance assessment <\/td>\n<\/tr>\n | ||||||
140<\/td>\n | 7.2.5\tDevice MRI safety 7.2.6\tAdditional implant design evaluation requirements <\/td>\n<\/tr>\n | ||||||
141<\/td>\n | 7.2.7\tDesign specific testing 7.2.8\tSimulated use 7.2.9\tHuman factors\/usability assessment 7.3\tPreclinical in vivo evaluation 7.3.1\tOverall requirements <\/td>\n<\/tr>\n | ||||||
142<\/td>\n | 7.3.2\tMethods <\/td>\n<\/tr>\n | ||||||
143<\/td>\n | 7.3.3\tTest report <\/td>\n<\/tr>\n | ||||||
144<\/td>\n | 7.4\tClinical investigation 7.4.1\tGeneral 7.4.2\tStatistical considerations 7.4.3\tDistribution of subjects and investigators 7.4.4\tSample size <\/td>\n<\/tr>\n | ||||||
145<\/td>\n | 7.4.5\tEntry criteria 7.4.6\tDuration of the study 7.4.7\tClinical data requirements <\/td>\n<\/tr>\n | ||||||
147<\/td>\n | 7.4.8\tClinical investigation report <\/td>\n<\/tr>\n | ||||||
149<\/td>\n | Annex\u00a0A (informative) Heart valve substitute hazards, associated failure modes, and evaluation methods <\/td>\n<\/tr>\n | ||||||
152<\/td>\n | Annex\u00a0B (informative) In vitro procedures for testing unstented or similar valves in compliant chambers <\/td>\n<\/tr>\n | ||||||
154<\/td>\n | Annex\u00a0C (informative) Preclinical in vivo evaluation <\/td>\n<\/tr>\n | ||||||
157<\/td>\n | Annex\u00a0D (informative) Description of the surgical heart valve substitute <\/td>\n<\/tr>\n | ||||||
159<\/td>\n | Annex\u00a0E (informative) Examples of components of some surgical heart valve substitutes <\/td>\n<\/tr>\n | ||||||
163<\/td>\n | Annex\u00a0F (informative) Guidelines for verification of hydrodynamic performance <\/td>\n<\/tr>\n | ||||||
172<\/td>\n | Annex\u00a0G (informative) Durability testing <\/td>\n<\/tr>\n | ||||||
174<\/td>\n | Annex\u00a0H (informative) Examples of design specific testing <\/td>\n<\/tr>\n | ||||||
176<\/td>\n | Annex\u00a0I (informative) Fatigue assessment <\/td>\n<\/tr>\n | ||||||
182<\/td>\n | Annex\u00a0J (normative) Methods of evaluating clinical data <\/td>\n<\/tr>\n | ||||||
183<\/td>\n | Bibliography <\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":" Tracked Changes. Cardiovascular implants. Cardiac valve prostheses – Surgically implanted heart valve substitutes<\/b><\/p>\n |